HALOZYME THERAPEUTICS, INC.: capex
| Value | {"amount": 2513000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2025-01-01 – 2025-06-30 |
| Status | current |
| Entity | HALOZYME THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:36:33.282397+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/b5449d3c-72ab-4b0a-bc62-3f3fb1abd395
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001159036-25-000034Retrieved: 2026-08-19T11:36:33.282397+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001159036/capex/2025-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/b5449d3c-72ab-4b0a-bc62-3f3fb1abd395
History
- no predecessors — first report